| 1 |
27784348 | [Expression and Clinical Significance of N-cadherin in Bone Marrow Leukemic Cells Derived from Patients with Acute Leukemia]. | 2016 Oct |
2 |
| 2 |
25876768 | An immunophenotypic pre-treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34+ CD38 low blasts. | 2015 Jul |
1 |
| 3 |
26171191 | Cluster of differentiation 96 as a leukemia stem cell-specific marker and a factor for prognosis evaluation in leukemia. | 2015 Jul |
1 |
| 4 |
25419423 | Immuno-phenotypes and prognosis of acute leukemia in elderly patients. | 2014 |
2 |
| 5 |
22040986 | [Proportion of CD34(+)CD38(-) cell population in bone marrow of patients with de novo AML as prognostic factor of complete remission at first course of induction chemotherapy]. | 2011 Oct |
1 |
| 6 |
18166216 | Autophagy as an ultrastructural marker of heavy metal toxicity in human cord blood hematopoietic stem cells. | 2008 Mar 15 |
1 |
| 7 |
16837044 | CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype. | 2007 Feb |
1 |
| 8 |
17340137 | CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. | 2007 May |
1 |
| 9 |
18056190 | Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome. | 2007 Dec 1 |
1 |
| 10 |
16179376 | Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. | 2006 Jan 15 |
1 |
| 11 |
16277848 | [CD34+ antigen expression relating to prognosis in acute myeloid leukemia]. | 2005 Oct |
1 |
| 12 |
14630079 | Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. | 2004 Jan |
1 |
| 13 |
15355691 | [The expression of CD133 in acute leukemia and its clinical significance]. | 2004 Jul |
1 |
| 14 |
14559689 | [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry]. | 2003 Oct |
1 |
| 15 |
10871740 | Effective high-dose chemotherapy combined with CD34+-selected autologous peripheral blood stem cell transplantation in a patient with cutaneous CD30-negative large T cell lymphoma. | 2000 Jun |
1 |
| 16 |
10602414 | Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics. | 1999 Dec |
1 |
| 17 |
9301680 | Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases. | 1997 Jul |
1 |
| 18 |
9447823 | High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate. | 1997 Dec |
1 |
| 19 |
7658724 | Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay. | 1995 Sep |
2 |
| 20 |
7526090 | P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML). | 1994 Nov |
3 |
| 21 |
7506635 | Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features. | 1993 Dec |
1 |
| 22 |
7690733 | CD34 expression fails to predict the outcome in adult acute myeloid leukemia. | 1993 May-Jun |
1 |
| 23 |
7693039 | Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. | 1993 Nov 15 |
1 |
| 24 |
1702006 | Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10) | 1990 Nov |
1 |